| # | Drug | Count |
|---|---|---|
| 0 | PROPRANOLOL HYDROCHLORIDE | 48 |
| 1 | DOXAZOSIN MESYLATE | 37 |
| 2 | METOCLOPRAMIDE HYDROCHLORIDE | 36 |
| 3 | DOXAZOSIN | 35 |
| 4 | METOPROLOL TARTRATE | 35 |
| 5 | METOCLOPRAMIDE | 34 |
| 6 | METOPROLOL | 34 |
| 7 | AMLODIPINE | 33 |
| 8 | ATENOLOL | 33 |
| 9 | METOPROLOL TARTRATE INJECTION | 25 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METYROSINE | 4 | 0.0494 |
| 1 | PHENTOLAMINE MESYLATE | 4 | 0.0247 |
| 2 | LEVOKETOCONAZOLE | 3 | 0.0040 |
| 3 | FLUDEOXYGLUCOSE F-18 | 1 | 0.0035 |
| 4 | DIMETICONE | 1 | 0.0035 |
| 5 | MINERAL OIL, WHITE PETROLATUM | 1 | 0.0035 |
| 6 | SELEGILINE HYDROCHLORIDE | 2 | 0.0034 |
| 7 | METHYLDOPA | 13 | 0.0026 |
| 8 | PHENELZINE SULFATE | 4 | 0.0025 |
| 9 | DEXTROMETHORPHAN HBR, GUAIFENESIN, DOXYLAMINE SUCCINATE | 1 | 0.0023 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 89 |
| 1 | beta-Adrenergic Blocker [EPC] | 65 |
| 2 | Dihydropyridine Calcium Channel Blocker [EPC] | 59 |
| 3 | Benzodiazepine [EPC] | 49 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 37 |
| 5 | Calcium Channel Blocker [EPC] | 33 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 27 |
| 7 | Proton Pump Inhibitor [EPC] | 26 |
| 8 | Insulin Analog [EPC] | 24 |
| 9 | Atypical Antipsychotic [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Catecholamine Synthesis Inhibitor [EPC] | 4 | 0.0494 |
| 1 | Cortisol Synthesis Inhibitor [EPC] | 3 | 0.0040 |
| 2 | Monoamine Oxidase Inhibitor [EPC] | 4 | 0.0013 |
| 3 | alpha-1 Adrenergic Agonist [EPC] | 4 | 0.0009 |
| 4 | Recombinant Human Growth Hormone [EPC] | 16 | 0.0007 |
| 5 | Catechol-O-Methyltransferase Inhibitor [EPC] | 3 | 0.0006 |
| 6 | Androgen [EPC] | 16 | 0.0006 |
| 7 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 8 | Antihypoglycemic Agent [EPC] | 2 | 0.0005 |
| 9 | alpha-Glucosidase Inhibitor [EPC] | 2 | 0.0004 |